Not available
Quote | VBI Vaccines Inc. (NASDAQ:VBIV)
Last: | $0.596 |
---|---|
Change Percent: | -1.16% |
Open: | $0.6 |
Close: | $0.603 |
High: | $0.62 |
Low: | $0.5806 |
Volume: | 85,743 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | VBI Vaccines Inc. (NASDAQ:VBIV)
2024-04-16 13:52:44 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips VBI Vaccines (NASDAQ: VBIV ) just reported results for the fourth quarter of 2023. VBI Vaccines reported earnings per share of -1 cent. This was above the analyst estimate...
2024-04-16 11:53:05 ET More on VBI Vaccines VBI Vaccines expands collaboration with Canadian government VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences Seeking Alpha’s Quant Rating on VBI Vaccines Historical earn...
Message Board Posts | VBI Vaccines Inc. (NASDAQ:VBIV)
Subject | By | Source | When |
---|---|---|---|
$VBIV no 1 in the Gaucho session | Monksdream | investorshub | 07/05/2023 8:23:32 PM |
Zoom Zoom WOOHOOOOOO WOOHOOOOOO $VBIV | weedtrader420 | investorshub | 07/05/2023 8:12:19 PM |
$VBIV: BBOOoooommmmmmmmm.............. moved now to $3.50 | makinezmoney | investorshub | 07/05/2023 8:02:51 PM |
$VBIV where is the squeeze? | cheynew | investorshub | 07/04/2023 4:43:59 PM |
$VBIV The gaining | cheynew | investorshub | 07/04/2023 11:59:28 AM |
News, Short Squeeze, Breakout and More Instantly...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 234% year-over-year from 2022 to 2023 Preliminary 2024 PreHevbrio U.S. sales demonstrate continued growth, with approximately 65% of 2023 full-year volume sold in Q1 2024 alone Early data from randomize...
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial resul...